Drugs Made In America Acquisition Stock (NASDAQ:DMAA)
Previous Close
$10.31
52W Range
$9.95 - $10.34
50D Avg
$10.28
200D Avg
$10.17
Market Cap
$346.23M
Avg Vol (3M)
$35.67K
Beta
2.82
Div Yield
-
DMAA Company Profile
Drugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.